Suicidal behaviour in youths with depression treated with new-generation antidepressants: Meta-analysis

British Journal of Psychiatry

Volumn 189, Issue NOV., 2006, Pages 393-398

  Dubicka, Bernadka ^a,b   Hadley, Sarah ^a   Roberts, Christopher ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b ROYAL MANCHESTER CHILDREN S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CITALOPRAM; FLUOXETINE; MIRTAZAPINE; PAROXETINE; SERTRALINE; VENLAFAXINE;

ADOLESCENT; ADULT; CHILD; CLINICAL TRIAL; DEPRESSION; HUMAN; JUVENILE; META ANALYSIS; REVIEW; RISK FACTOR; SUICIDAL BEHAVIOR; SYSTEMATIC REVIEW;

ADOLESCENT; ANTIDEPRESSIVE AGENTS; DEPRESSIVE DISORDER; HUMANS; RANDOMIZED CONTROLLED TRIALS; RISK FACTORS; SELF-INJURIOUS BEHAVIOR; SEROTONIN UPTAKE INHIBITORS; SUICIDE, ATTEMPTED;

EID: 33750593026     PISSN: 00071250     EISSN: None     Source Type: Journal    
DOI: 10.1192/bjp.bp.105.011833     Document Type: Review

References (29)

1. American College of Neuropsychopharmacology (2004) Executive Summary. Preliminary Report of the Task Force on SSRIs and Suicidal Behaviour in Youth. Washington, DC: American College of Neuropsychopharmacology.
2. Bradburn, M. J., Deeks, J. J. & Altman, D. F. (1999) Metan - an alternative meta-analysis command. Stata Technical Bulletin Reprints, 8, 86-100.
3. Cheung, A. H., Emslie, G. J., Mayes, T. L., et al (2005) Review of the efficacy and safety of antidepressants in youth depression. Journal of Child Psychology and Psychiatry, 46, 735-754.
4. DerSimonian, R. & Laird, N. (1986) Meta-analysis in clinical trials. Controlled Clinical Trials, 7, 177-188.
5. Emslie, G., Rush, A., Weinberg, W., et al (1997) A double-blind, randomized placebo-controlled trial of fluoxetine in depressed children and adolescents. Archives of General Psychiatry, 54, 1031-1037.
6. Emslie, G. J., Heiligenstein, J. H., Wagner, K. D., et al (2002) Fluoxetine for acute treatment of depression in children and adolescents: a placebo-controlled randomised clinical trial. Journal of the American Academy of Child and Adolescent Psychiatry, 41, 1205-1215.
7. Fergusson, D., Doucette, S., Glass, C. K., et al (2005) Association between suicide attempts and selective serotonin reuptake inhibitors: systematic review of randomised controlled trials. BMJ, 330, 396-399.
8. Food and Drug Administration Center for Drug Evaluation and Research (2004a) Suicidality in Pediatric Clinical Trials of Antidepressant Drugs: Comparison Between Previous Analyses and Colombia University Classification. Washington, DC: FDA (http://www.fda.gov/ohrms/dockets/ac/04/briefing/2004- 4065b1-11-TAB09a-Mosholder-review.pdf).
9. Food and Drug Administration Center for Drug Evaluation and Research (2004b) Review and Evaluation of Clinical Data. Washington, DC: FDA (http://www.fda.gov/ohrms/dockets/ac/04/briefing/2004-4-065b1-10-TAB08-Hammads- review.pdf).
10. Food and Drug Administration Center for Drug Evaluation and Research (2004c) Summary Comments on Antidepressants and Suicidality in Pediatric Patients and Questions/Topics for Comment. Washington, DC: FDA (http://www.fda.gov/ohrms/dockets/ac/04/slides/20-04-4065S2_01_Laughren_files/ frame.htm).
11. Food and Drug Administration Center for Drug Evaluation and Research (2004d) FDA Statement on Recommendations of the Psychopharmacologic Drugs and Pediatric Advisory Committee. Washington, DC: FDA (http://www.fda.gov/bbs/ topics/news/2004/NEW01116.html).
12. Food and Drug Administration Center for Drug Evaluation and Research (2004e) Background Comments for February 2, 2004 Meeting of Psychopharmacological Drugs Advisory Committee (PDAC) and Pediatric Subcommittee of the Anti-Infective Drugs Advisory Committee (Peds AC). Washington, DC: FDA (http://www.fda.gov/ohrms/dockets/ac/04/briefing/2004-4065b1-04-Tab02-Laughren- Jan5.pdf).
13. Food and Drug Administration Center for Drug Evaluation and Research (2005) FDA Reviews Data for Antidepressant Use in Adults. Washington, DC: FDA (http://www.fda.gov/bbs/topics/ANSWERS/2005/ANS01362.html).
14. Gunnell, D. & Ashby, D. (2004) Antidepressants and suicide: what is the balance of benefit and harm. BMJ, 329, 34-38.
15. Gunnell, D., Saperia, J. & Ashby, D. (2005) Selective serotonin reuptake inhibitors (SSRIs) and suicide in adults: meta-analysis of drug company data from placebo controlled, randomised controlled trials submitted to the MHRA's safety review. BMJ, 330, 385-388.
16. Harrington, R. C., Bredenkamp, D., Groothues, C., et al (1994) Adult outcomes of childhood and adolescent depression. III. Links with suicidal behaviours. Journal of Child Psychology and Psychiatry, 35, 1380-1391.
17. Jureidini, J. N., Doecke, C. J., Mansfield, P. R., et al (2004) Efficacy and safety of antidepressarrts for children and adolescents. BMJ, 328, 879-883.
18. Keller, M. B., Ryan, N. D., Strober, M., et al (2001) Efficacy of paroxetine in the treatment of adolescent major depression: a randomized, controlled trial. Journal of the American Academy of Child and Adolescent Psychiatry, 40, 762-772.
19. Marttunen, M. J., Aro, H. M. & Lonnqvitt, J. K. (1993) Adolescence and suicide: a review of psychological autopsy studies. European Child and Adolescent Psychiatry, 2, 10-18.
20. Medicines and Healthcare Products Regulatory Agency (2004) Report of the CSM Expert Working Group on the Safety of Selective Serotonin Reuptake Inhibitor Antidepressants. London: Committee on Safety of Medicines (http://www.mhra.gov. uk/home/groups/pl-p/documents/drugsafetymessage/con019472.pdf).
21. Meltzer, H., Harrington, R., Goodman, R., et al (2001) Children and Adolescents Who Try to Harm, Hurt or Kill Themselves. A Report of Further Analysis from the National Survey of the Mental Health of Children and Adolescents in Great Britain in 1999. London: Office for National Statistics.
22. National Collaborating Centre for Mental Health (2004) Quick Reference Guide. Depression: Management of Depression in Primary and Secondary Care. Clinical Guideline 23. London: National Institute for Clinical Excellence (http://www.nice.org.uk/pdf/CG023quickrefguide.pdf).
23. Rao, U., Weissman, M. M., Martin, J. A., et al (1991) Childhood depression and risk of suicide: preliminary report of a longitudinal study. Journal of the American Academy of Child and Adolescent Psychiatry, 32, 21-27.
24. Shaffer, D., Gould, M. S., Fisher, P., et al (1996) Psychiatric diagnosis in child and adolescent suicide. Archives of General Psychiatry, 53, 339-348.
25. Sutton, A. J., Abrams, K., Jones, D. R., et al (2000) Methods for Meta-analysis in Medical Research. Chichester: John Wiley & Sons.
26. Treatment for Adolescents with Depression Study Team (2004) Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression. JAMA, 292, 807-820.
27. Wagner, K. D., Ambrosini, P., Rynn, M., et al (2003) Efficacy of sertraline in the treatment of children and adolescents with major depressive disorder. JAMA, 290, 1033-1041.
28. Wagner, K. D., Robb, A. S., Findling, R. L., et al (2004) A randomised, placebo-controlled trial of citalopram for the treatment of major depression in children and adolescents. American Journal of Psychiatry, 161, 1079-1083.
29. Whittington, C. J., Kendall, T., Fonagy, P., et al (2004) Selective serotonin reuptake inhibitors in childhood depression: systematic review of published versus unpublished data. Lancet, 363, 1341-1345.